Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Kenvue

Kenvue Joins S&P 500 on Friday: Time to Buy?

S&P Dow Jones Indices announced on Monday that Kenvue would join the S&P 500 on Friday. Tuesday’s volume and rising share price suggest that investors feel now is the time to buy its stock.

Barchart

Strength in Technology Stocks Leads the Overall Market Higher

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.65%. Stocks on Monday settled mostly higher on a rally...

Barchart

Stocks Mixed as Bond Yields Climb

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.65%. Stocks this morning are mixed. An increase in M&A...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Newest Fortune 500 member says large companies lose focus: 'You are little more remote from where the action is'

Kenvue, spun off from Johnson & Johnson in May, generated $15 billion in sales last year, enough to put it at rank 275 on 2022's Fortune 500 list.

Fortune

Johnson & Johnson Spins Off Kenvue in Biggest IPO Haul Since 2021

Johnson & Johnson rips off Band-Aid and spits out Listerine in a bid to boost margins.

Kiplinger

The Best Medical Stock That Money Can Buy

The medical industry, which thrived during the pandemic years, is envisioned to remain buoyed despite the economic headwinds, thanks to the inelastic demand the sector faces. Against this backdrop, we think the strong fundamentals of Johnson and Johnson (JNJ) make it a wise portfolio addition. Read on….

StockNews.com

2 Stocks That'll Help You Keep Money in Your Pockets

Rising anxieties owing to the likelihood of an impending recession have weighed heavily on the stock market. Given the uncertainties are not likely to ease anytime soon, quality stocks Johnson & Johnson (JNJ) and Pfizer (PFE) might be wise portfolio additions to help you keep money in your pockets. Read…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

1 2 3 4 5

People

Sristi Suman JayaswalThe

216 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.